Uncategorized

Emergent BioSolutions’ stock soars 23% after FDA approves its smallpox vaccine for mpox

By August 30, 2024No Comments1 Min Read

Previous ArticleWe’re in our 60s and plan to claim Social Security at 70. Does delaying for maximum benefits really make sense?

Next Article Lululemon’s mixed earnings report hasn’t changed analysts’ minds

Leave a ReplyCancel reply